Inhallation of e-Cigarette Cartridge Solution Aggravates Allergen-induced Airway Inflammation and Hyper-responsiveness in Mice

  • Lim, Heung Bin (Department of Industrial Crop Science and Technology, Chungbuk National University) ;
  • Kim, Seung Hyung (Institute of Traditional Medicine and Bioscience, Daejeon University)
  • Received : 2013.12.26
  • Accepted : 2014.03.22
  • Published : 2014.03.31


Electronic cigarettes (e-cigarettes) are becoming increasingly popular worldwide and their cellular effects warrant further evaluation. In this study, we investigated the effects of an e-cigarette cartridge solution on allergen related asthmatic airway inflammation (AI) and airway hyperresponsiveness (AHR), when it is delivered by intratracheal route in mice. Asthmatic AI and AHR were induced by systemic sensitization to ovalbumin (OVA) followed by intratracheal, intraperitoneal, and aerosol allergen challenges in BALB/c mice. The cartridge solution of e-cigarette (containing 16 mg/ml nicotine) was diluted 50 times and $100{\mu}l$ of the diluted solution was intratracheally instilled to OVA-sensitized (OVA-S) mice two times a week for 10 weeks. Long-term e-cigarette inhalation elicited no remarkable changes in the activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase enzymes in serum, however, increased infiltration of inflammatory cells including eosinophils, into airways from blood, aggravated the asthmatic AI and AHR, and stimulated the production of cytokines such as interleukin (IL)-4, IL-5 and IL-13, and OVA-specific IgE production. Our data suggest that the inhalation of e-cigarette solutions can function as an important factor to exacerbate the allergy-induced asthma symptoms. Further studies are needed to address the effects of e-cigarette solutions on human health.



  1. Uryupin, A.B., Peregudov, A.S., Kochetkov, K.A., Bulatnikova, L.N., Kiselev, S.S. and Nekrasov, Y.S. (2013) Qualitative and quantitative compositions of fluids for electronic cigarettes. Pharm. Chem. J., 46, 687-692.
  2. Polosa, R., Caponnetto, P., Morjaria, J.B., Papale, G., Campagna, D. and Russo, C. (2011) Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health, 11, 786.
  3. Ingebrathsen, B.J., Cole, S.K. and Alderman, S.L. (2012) Electronic cigarette aerosol particle size distribution measurements. Inhalation Toxicol., 24, 976-984.
  4. Kuschner, W.G., Reddy, S., Mehrotra, N. and Paintal, H.S. (2011) Electronic cigarettes and thirdhand tobacco smoke: two emerging health care challenges for the primary care provider. Int. J. Gen. Med., 4, 115-120.
  5. Lee, S., Kimm, H., Yun, J.E. and Jee, S.H. (2011) Public health challenges of electric cigarettes in South Korea. J. Prev. Med. Public Health, 44, 235-241.
  6. Laugesen, M. (2008) Safety report on the Ruyan e-cigarette cartridge and inhaled aerosol, Health New Zealand Ltd, New Zealand, pp. 1-23.
  7. Food and Drug Administration. (2010) Summary of Results: Laboratory Analysis of Electronic Cigarettes Conducted By FDA, FDA, US, pp. 1.
  8. Etter, J.F. (2010) Electronic cigarettes: a survey of users. BMC Public Health, 10, 231.
  9. Caponnetto, P., Auditore, R., Russo, C., Cappello, G.C. and Polosa, R. (2013) Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: A prospective 12-month pilot study. Int. J. Environ. Res. Public Health, 10, 446-461.
  10. Flouris, A.D., Chorti, M.S., Poulianiti, K.P., Jamurtas, A.Z., Kostikas, K., Tzatzarakis, M.N., Wallace Hayes, A., Tsatsakis, A.M. and Koutedakis, T. (2013) Acute impact of active and passive electronic cigarette smoking on serum cotinin and lung function. Inhalation Toxicol., 25, 91-101.
  11. Siegel, M.B., Tanwar, K.L. and Wood, K.S. (2011) Electronic cigarettes as a smoking-cessation tool. Results from an online survey. Am. J. Prev. Med., 40, 472-475.
  12. Etter, J.F. and Bullen, C. (2011) Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction, 106, 2017-2028.
  13. Vansickel, A.R., Cobb, C.O., Weaver, M.F. and Eissenberg, T.E. (2010) A clinical laboratory model for evaluating the acute effects of electronic ''cigarettes'': nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol. Biomarkers Prev., 19, 1945-1953.
  14. Bullen, C., McRobbie, H., Thornley, S., Glover, M., Lin, R. and Laugesen, M. (2010) Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob. Control, 19, 98-103.
  15. Kim, D.S., Kim, S.H., Kim, B.K., Yang, M.C. and Ma, J.Y. (2012) Antiasthmatic effects of herbal complex MA and its fermented product MA128. Evid. Based Complement. Altern. Med., 2012, 769508.
  16. Kim, S.H., Kim, B.K. and Lee, Y.C. (2011) Antiasthmatic effects of hesperidin, a potential Th2 cytokine antagonist, in a mouse model of allergic asthma. Mediators Inflammation, 2011, 485402.
  17. Cieslewicz, G., Tomkinson, A., Adler, A., Duez, C., Schwarze, J., Takeda, K., Larson, K.A., Lee, J.J., Irvin, C.G. and Gelfand, E.W. (1999) The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J. Clin. Invest., 104, 301-308.
  18. Lee, Y.C., Kim, S.H., Seo, Y.B., Roh, S.S. and Lee, J.C. (2006) Inhibitory effects of Actinidia polygama extract and cyclosporine A on OVA-induced eosinophilia and bronchial hyperresponsiveness in a murine model of asthma. Int. Immunopharmacol., 6, 703-713.
  19. Barnes, P.J. (2011) Pathophysiology of allergic inflammation. Immunol. Rev., 242, 31-50.
  20. Barlow, R.B. and McLeod, L.J. (1969) Some studies on cytosine and its methylated derivatives. Br. J. Pharmacol., 35, 161-174.
  21. Tomkinson, A., Duez, C., Cieslewicz, G., Pratt, J.C., Joetham, A., Shanafelt, M.C., Gundel, R. and Gelfand, E.W. (2001) A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J. Immunol., 166, 5792-5800.
  22. Bates, J.H. and Maksym, G.N. (2011) Mechanical determinants of airways hyperresponsiveness. Crit. Rev. Biomed. Eng., 39, 281-296.
  23. Cockcroft, D.W. (2010) Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest, 138, 18S-24S.
  24. Nakagome, K. and Nagata, M. (2011) Pathogenesis of airway inflammation in bronchial asthma. Auris Nasus Larynx, 38, 555-563.
  25. Brightling, C.E. (2011) Eosinophils, bronchitis and asthma; Pathogenesis of cough and air flow obstruction. Pulm. Pharmacol. Ther., 24, 324-327.
  26. Amin, K. (2012) The role of mast cells in allergic inflammation. Respir. Med., 106, 9-14.
  27. Bosnjak, B., Stelzmueller, B., Erb, K.J. and Epstein, M.M. (2011) Treatment of allergic asthma: Modulation of Th2 cells and their responses. Respir. Res., 12, 114.

Cited by

  1. Electronic cigarettes: ‘Vaping’ has unproven benefits and potential harm vol.19, pp.7, 2014,
  2. Association between Electronic Cigarette Use and Asthma among High School Students in South Korea vol.11, pp.3, 2016,
  3. Electronic cigarettes: what are they and what do they do? vol.1394, pp.1, 2016,
  4. Neurobehavioral assessment following e-cigarette refill liquid exposure in adult rats vol.26, pp.6, 2016,
  5. Impact of e-cigarette refill liquid with or without nicotine on liver function in adult rats vol.26, pp.6, 2016,
  6. Development and characterization of electronic-cigarette exposure generation system (Ecig-EGS) for the physico-chemical and toxicological assessment of electronic cigarette emissions vol.28, pp.14, 2016,
  7. Hypothesis: may e-cigarette smoking boost the allergic epidemic? vol.6, pp.1, 2016,
  8. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner vol.71, pp.12, 2016,
  9. Trendy e‑cigarettes vol.12, pp.1, 2017,
  10. Electronic Cigarette Use and Respiratory Symptoms in Adolescents vol.195, pp.8, 2017,
  11. 2-Hydroxy-3-methoxybenzoic acid attenuates mast cell-mediated allergic reaction in mice via modulation of the FcεRI signaling pathway vol.38, pp.1, 2017,
  12. Association between electronic cigarette smoking and allergic rhinitis – The Korea National Health and Nutrition Examination Survey (2015) vol.5, pp.6, 2017,
  13. Will chronic e-cigarette use cause lung disease? vol.309, pp.12, 2015,
  14. Phagocytosis and Inflammation: Exploring the effects of the components of E-cigarette vapor on macrophages vol.5, pp.16, 2017,
  15. The effects of electronic cigarette aerosol exposure on inflammation and lung function in mice vol.313, pp.1, 2017,
  16. vol.88, pp.4, 2017,
  17. Myofibroblast differentiation and its functional properties are inhibited by nicotine and e-cigarette via mitochondrial OXPHOS complex III vol.7, pp.1, 2017,
  18. Pulmonary toxicity of e-cigarettes vol.313, pp.2, 2017,
  19. Comparison of the effects of e-cigarette vapor with cigarette smoke on lung function and inflammation in mice vol.315, pp.5, 2018,
  20. Elaeocarpusin Inhibits Mast Cell-Mediated Allergic Inflammation vol.9, pp.1663-9812, 2018,
  21. Environmental exposures and mechanisms in allergy and asthma development pp.1558-8238, 2019,
  22. Vaping and Orthopaedic Surgery vol.7, pp.1, 2019,